Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Astex celebrates as breast cancer drug gets European marketing approval

Astex celebrates as breast cancer drug gets European marketing approval

BioAscent to manage Medivir’s expanding compound library

BioAscent to manage Medivir’s expanding compound library

Researchers use small molecule to relieve symptoms of Rett syndrome in mouse model

Researchers use small molecule to relieve symptoms of Rett syndrome in mouse model

Id genes found to play crucial role in heart development

Id genes found to play crucial role in heart development

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

Insilico and GSK collaborate to enhance drug discovery process

Insilico and GSK collaborate to enhance drug discovery process

Livecyte® Kinetic Cytometer system by Phasefocus wins 2017 Microscopy Today Innovation Award

Livecyte® Kinetic Cytometer system by Phasefocus wins 2017 Microscopy Today Innovation Award

Scientists create stem cell-based model of rare inherited neurological condition

Scientists create stem cell-based model of rare inherited neurological condition

Cryo-electron microscopy advances by Thermo Fisher Scientific drives structural biology research

Cryo-electron microscopy advances by Thermo Fisher Scientific drives structural biology research

Bioactive 'tissue papers' show potential for regenerative medicine

Bioactive 'tissue papers' show potential for regenerative medicine

New way of screening compounds may help speed up drug development

New way of screening compounds may help speed up drug development

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

Scientists reveal new method to reprogram specific T cells

Scientists reveal new method to reprogram specific T cells

Takeda and Cardurion announce creation of new cardiovascular development partnership

Takeda and Cardurion announce creation of new cardiovascular development partnership

New partnership uses artificial intelligence methods to develop solutions for preventing early aging

New partnership uses artificial intelligence methods to develop solutions for preventing early aging

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

Juvenescence AI to develop first compounds generated by Insilico's deep-learned drug discovery engines

New method may help distinguish frontotemporal dementia from Alzheimer's disease

New method may help distinguish frontotemporal dementia from Alzheimer's disease

Nanomedical Diagnostics introduces new NTA biosensor for faster, reliable characterization of proteins

Nanomedical Diagnostics introduces new NTA biosensor for faster, reliable characterization of proteins

Likarda uses INTEGRA’s VIAFLO ASSIST to automate cell-based assay development

Likarda uses INTEGRA’s VIAFLO ASSIST to automate cell-based assay development

Researchers devise strategy to target Achilles heel of nervous system cancers

Researchers devise strategy to target Achilles heel of nervous system cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.